5 research outputs found
Eosinophilia Due to Central Venous Catheter in Hemodialysis Patients
International audienceNo abstract availabl
Unique and specific Agrobacterium diversity in urinary microbiota of tolerant kidney transplanted recipients
International audienceHostâmicrobiota interactions can modulate the immune system both at local and systemic levels, with potential consequences for organ transplantation outcomes. In this study, we hypothesized that differences in the urinary microbiome following kidney transplantation would be associated with posttransplantation status: stable, minimally immunosuppressed, or tolerant. One hundred thirteen urine samples from stable (n = 51), minimally immunosuppressed (n = 19), and spontaneously tolerant (n = 16) patients, paired with ageâmatched controls (n = 27) were profiled and compared to each other at a taxonomic level with special interest in the immunosuppressive regimen. All comparisons and correlations were adjusted on sex and time posttransplantation. Our results highlighted a unique and specific urinary microbiota associated with spontaneous tolerance characterized by a high diversity and a clear Proteobacteria profile. Finally, we report that this profile is (1) impacted by gender, (2) inversely correlated with immunosuppressive drugs (calcineurin inhibitors and mammalian target of rapamycin inhibitors), and (3) stable in time
Comparison of machine perfusion versus cold storage in kidney transplant recipients from expanded criteria donors: a cohort-based study
International audienceBackground Most studies comparing the efficacy of hypothermic machine perfusion (HMP) versus static cold storage (SCS) are based on short-term outcomes. We aimed to better evaluate the mid-term impact of HMP in patients receiving expanded criteria donor (ECD) kidneys. Methods The analyses were based on the French DonnĂ©es InformatisĂ©es et VAlidĂ©es en Transplantation (DIVAT) observational cohort. Patients aged â„45âyears transplanted for the first or second times from an ECD donor since 2010 were studied. Our study reported the graft and/or patient survivals and the incidence of acute rejection episode. The Cox models and the KaplanâMeier estimators, weighted on the propensity score, were used to study the times-to-events. Results Among the 2019 included patients, 1073 were in the SCS group versus 946 in the HMP group. The mean life expectancy with functioning graft was 5.7âyears [95% confidence interval (CI) 5.4â6.1] for the HMP cohort followed-up for 8âyears post-transplantation versus 6.0âyears (95% CI 5.7â6.2) for the SCS group. These mid-term results were comparable in the patients receiving grafts from donors aged â„70 years and in the transplantations with cold ischaemia time â„18âh. Conclusions Our study challenges the utility of using HMP to improve mid-term patient and graft survival. Nevertheless, the improvement of the short-term outcomes is indisputable. It is necessary to continue technological innovations to obtain long-term results